Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2023-03-03 Annual Report
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
10-K
Annual Report FY 2022
2023-03-03 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by OraSure Technologies, Inc. It includes announcements of financial results for the full year and quarter ended December 31, 2022, a press release attached as an exhibit, a webcast conference call with management discussing the results, and a business restructuring announcement. The document does not contain the full financial statements or detailed financial analysis itself but rather references and attaches a press release with the financial results. The Form 8-K is a regulatory filing used to report major events and updates but is not itself an earnings release or annual/interim report. The presence of a press release announcing financial results and a conference call discussion aligns with an Earnings Release (ER) filing. The document length is about 5,484 characters, which is consistent with an earnings release announcement rather than a full report. Therefore, the best classification is Earnings Release (ER).
2023-02-14 English
SCHEDULE 13G/A
Major Shareholding Notification
2023-02-09 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-02-07 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2023-02-02 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2023-02-02 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.